Gollob Jared
SEC CIK 1821198 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Chief Medical Off | 117.1K | — | $16.52M | 24 | 2021-11-01 | 2026-03-02 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-02+ | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale | $87.24 | -10.5K | 117.1K | -8% | -$916.7K |
| D | 2026-03-04 | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +17.6K | 127.6K | +16% | $0 |
| DMT | 2025-12-08 | 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $88.66 | -49.3K | 110.0K | -31% | -$4.37M |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $5.33 | +49.3K | 159.3K | +45% | +$262.8K |
| DMT | 2025-10-15 | 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $1.64 | +51.2K | 147.4K | +53% | +$84.2K |
| DMT | 2025-10-15 | 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $61.42 | -59.6K | 131.3K | -31% | -$3.66M |
| DMT | 2025-10-14 | 2025-10-13 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $1.66 | +1,473 | 120.8K | +1% | +$2,448 |
| DT | 2025-10-14 | 2025-10-13 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $60.00 | -3,114 | 118.4K | -3% | -$186.8K |
| DM | 2025-03-03 | 2025-03-03 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale | $30.45 | -5,740 | 121.0K | -5% | -$174.8K |
| D | 2025-03-03 | 2025-03-03 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +30.0K | 125.7K | +31% | $0 |
| DMT | 2024-07-16 | 2024-07-15+ | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $45.53 | -39.6K | 95.7K | -29% | -$1.80M |
| DMT | 2024-07-16 | 2024-07-15+ | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $2.08 | +39.6K | 112.2K | +55% | +$82.4K |
| D | 2024-03-04 | 2024-03-01 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +24.4K | 99.1K | +33% | $0 |
| DM | 2024-03-04 | 2024-03-04 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale | $41.85 | -3,344 | 95.7K | -3% | -$140.0K |
| DT | 2024-02-29 | 2024-02-27 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $2.08 | +400 | 75.1K | +0.5% | +$832 |
| DT | 2024-02-29 | 2024-02-27 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $45.00 | -400 | 74.7K | -0.5% | -$18.0K |
| DT | 2024-02-09 | 2024-02-09 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $2.08 | +46.1K | 120.8K | +62% | +$96.0K |
| DMT | 2024-02-09 | 2024-02-09 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $35.50 | -46.1K | 74.7K | -38% | -$1.64M |
| DM | 2023-03-03 | 2023-03-02 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale | $31.00 | -1,298 | 74.7K | -2% | -$40.2K |
| D | 2023-03-03 | 2023-03-01 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +18.8K | 76.0K | +33% | $0 |
| DM | 2022-05-04 | 2022-05-04 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $1.69 | +20.0K | 57.3K | +54% | +$33.7K |
| D | 2022-03-03 | 2022-03-01 | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +12.6K | 37.3K | +51% | $0 |
| DM | 2021-11-02 | 2021-11-01+ | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | S - Sale+OE | $62.16 | -57.5K | 44.6K | -56% | -$3.57M |
| DM | 2021-11-02 | 2021-11-01+ | KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Off | M - OptEx | $1.69 | +39.6K | 62.5K | +173% | +$67.0K |
Purchase Sale Sale after option exercise All abbreviations